Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling of pharmaceutical products. The company is headquartered in Yantai, Shandong and currently employs 5,115 full-time employees. The company went IPO on 2014-07-09. The firm operates four segments, including Oncology Drugs segment, Cardiovascular System Drugs segment, Alimentary Tract and Metabolism Drugs segment, and Central Nervous System Drugs segment. The Oncology Drugs segment provides Lipusu, Boyounuo, Baituowei, CMNa and Mimeixin and other drugs. The Cardiovascular System Drugs segment provides Xuezhikang, Oukai and Maitongna and other drugs. The Alimentary Tract and Metabolism Drugs segment provides Bei Xi and other drugs. The Central Nervous System Drugs segment provides Seroquel, Ruoxinlin, Rykindo, Meibirui and Jinyouping and other drugs.
02186.HK stock price ended at $2.7 on Cuma, after rising 1.12%
On the latest trading day Feb 13, 2026, the stock price of 02186.HK rose by 1.12%, climbing from $2.67 to $2.70. Throughout the session, the stock experienced a volatility of 2.26%, with prices fluctuating between a daily low of $2.65 and a high of $2.71. Alongside this price increase, trading volume also rose by 4.0M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 11.4M shares were traded, amounting to a market value of approximately $10.7B.
02186.HKTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 1
Nötr Sinyaller 2
Satış Sinyalleri 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
02186.HK, şu anda 1 alım sinyali ve 4 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Yukarı trend durumundadır ve bu dönemde toplam 1.12% fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Sell görünüm işaret etmektedir.
02186.HK için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek 02186.HK için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.